David Alan Campbell
Chief Executive Officer at Janux Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Janux Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Janux Therapeutics Inc. June 11, 202582.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | Janux Therapeutics Inc. | Gift | −123,840 | — | — |
| Jul 8, 2026 | Janux Therapeutics Inc. | Option exercise | +7,000 | $4.21 | $29,470 |
| Jan 2, 2026 | Janux Therapeutics Inc. | Open-market sale | −8,072 | $13.73 | $110,829 |
| Jan 2, 2026 | Janux Therapeutics Inc. | Grant or award | +96,600 | — | — |
| Jan 7, 2025 | Janux Therapeutics Inc. | Open-market sale | −5,000 | $60.00 | $300,000 |
| Jan 2, 2025 | Janux Therapeutics Inc. | Grant or award | +81,000 | — | — |
| Dec 24, 2024 | Janux Therapeutics Inc. | Open-market sale | −25,000 | $56.19 | $1,404,750 |
| Dec 3, 2024 | Janux Therapeutics Inc. | Open-market sale | −15,000 | $67.00 | $1,005,000 |
| Nov 25, 2024 | Janux Therapeutics Inc. | Open-market sale | −18,281 | $51.43 | $940,192 |
| Nov 25, 2024 | Janux Therapeutics Inc. | Open-market sale | −6,719 | $52.04 | $349,657 |
| Oct 28, 2024 | Janux Therapeutics Inc. | Open-market sale | −13,897 | $53.22 | $739,598 |
| Oct 28, 2024 | Janux Therapeutics Inc. | Open-market sale | −11,103 | $53.94 | $598,896 |
| Sep 27, 2024 | Janux Therapeutics Inc. | Open-market sale | −18,957 | $46.09 | $873,728 |
| Sep 27, 2024 | Janux Therapeutics Inc. | Open-market sale | −5,248 | $46.86 | $245,921 |
| Sep 27, 2024 | Janux Therapeutics Inc. | Open-market sale | −795 | $47.84 | $38,033 |
Questions about David Alan Campbell
What boards is David Alan Campbell on?
David Alan Campbell sits on the board of Janux Therapeutics Inc.
What company is David Alan Campbell the CEO of?
David Alan Campbell is Chief Executive Officer of Janux Therapeutics Inc.
How long has David Alan Campbell served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.